Led by the Georgia Institute of Technology, the NSF Engineering Research Center for Cell Manufacturing Technologies could help revolutionize the treatment of cancer, heart disease, autoimmune diseases, and other disorders

New benchtop design and expanded assay portfolio offers researchers greater access to ultra-sensitive Simoa technology for unrivaled biomarker detection

Researchers hope that by precisely modulating how our immune system responds to infection, they can develop new therapies that can be used to treat people with these serious diseases

Broad inadequacies in a widespread biological concept that affects cancer research could be significantly deflecting the aim of such targeted drugs, according to a new study

Drug zeroes in on mutated nuclear receptors found in cancer, leaves normal proteins alone

Their research gives oncologists a better shot at overcoming the problems of drug resistance, toxicity to patients, and a host of other barriers to consistently achieving successful gene therapy for cancer

An international study was launched when researchers found that another inhibitor for advanced cancers, called OTS167, had a negative outcome in a clinical trial

New approach could prove to be beneficial in healing challenging wounds in diabetics and major-burn victims

Penn researchers find blocking the activity of the ANGPTL3 protein strongly lowers triglycerides and cholesterol in pilot clinical trial

The findings, published online May 18 in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines